Otlertuzumab

Otlertuzumab
Monoclonal antibody
Type ?
Source Humanized (from mouse)
Target CD37
Clinical data
ATC code none
Identifiers
CAS Number 1372645-37-8
ChemSpider none
Chemical and physical data
Formula C4660H7136N1246O1452S30
Molar mass 107.5 kg/mol

Otlertuzumab is a humanized monoclonal antibody designed for the treatment of cancer.[1]

This drug was developed by Emergent BioSolutions.

References

  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Otlertuzumab, American Medical Association.
This article is issued from Wikipedia - version of the 2/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.